EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSPLOG00000013828
Gene Symbol: DHCR24
4 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSPLOG00000002361
Gene Symbol: HMGCR
2 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSPLOG00000022307
Gene Symbol: PDPK1
4 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSPLOG00000009418
Gene Symbol: HPD
4 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S20-Like

Ensembl ID : ENSPLOG00000012401
Gene Symbol: LOC122227222
3 Cross references
142 Possible Orthologues:

40s Ribosomal Protein S23-Like

Ensembl ID : ENSPLOG00000012636
Gene Symbol: LOC122217057
3 Cross references
183 Possible Orthologues:

40s Ribosomal Protein S29-Like

Ensembl ID : ENSPLOG00000000109
Gene Symbol: LOC122217240
3 Cross references
72 Possible Orthologues:

40s Ribosomal Protein S29-Like

Ensembl ID : ENSPLOG00000001501
Gene Symbol: LOC122201776
3 Cross references
130 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSPLOG00000013309
Gene Symbol: NT5E
4 Cross references
249 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSPLOG00000005760
Gene Symbol: HTR1A
4 Cross references
147 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSPLOG00000020635
Gene Symbol: HTR1B
4 Cross references
245 Possible Orthologues:

5-Hydroxytryptamine Receptor 1d

Ensembl ID : ENSPLOG00000008052
Gene Symbol: HTR1D
4 Cross references
67 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).